Understanding how social factors affect metabolic syndrome and heart disease risk.
Metabolic Syndrome Severity in All of Us: Relationship with Social Determinants of Health and with Long-Term Risk for Cardiovascular Disease
This study is looking at how things like your background and living conditions affect the severity of metabolic syndrome, especially in diverse communities, to help create better health tools and personalized care for everyone.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10925423 on NIH RePORTER |
What this research studies
This research investigates the relationship between metabolic syndrome severity and social determinants of health, particularly among minoritized groups. It aims to validate assessment tools that can help track metabolic syndrome, which is a cluster of risk factors for cardiovascular disease. By analyzing data from diverse populations, including African Americans and Asian Americans, the study seeks to develop personalized medicine approaches that consider unique health profiles and stress factors. Participants may contribute to a better understanding of how these factors influence long-term health outcomes.
Who could benefit from this research
Good fit: Ideal candidates include individuals from minoritized racial and ethnic groups who may be at risk for metabolic syndrome and cardiovascular disease.
Not a fit: Patients who do not belong to the targeted minoritized groups or those without metabolic syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing cardiovascular disease in diverse populations.
How similar studies have performed: Previous research has shown success in using similar approaches to assess health disparities and metabolic syndrome in diverse populations.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Gurka, Matthew James — University of Virginia
- Study coordinator: Gurka, Matthew James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.